YARAL Pharma, Inc., which launched in 2022, is the U.S. generics subsidiary of IBSA, a long-standing, fully integrated, multinational pharmaceutical company headquartered in Lugano, Switzerland. Yaral is committed to providing high-quality products across a range of therapeutic areas, ensuring continuity of supply, and offering affordable authorized generics and complex generic medicines. In this episode, we focus on IBSA's innovative patch and Softgel technologies and how YARAL Pharma leverages this technology, aiming to reshape the landscape of patient care and pharmaceutical excellence.